Sample Preparation Market - Databook 2025 to 2034

The global sample preparation market size accounted for USD 7,900 million in 2024 and is predicted to touch around USD 14,420 million by 2034, growing at a CAGR of 6.2% from 2025 to 2034.

Highlights of the Sample Preparation Market

• North America dominated the global sample preparation market in 2024.
• Asia Pacific is anticipated to grow at the fastest rate in the market during the forecast period.
• By product, the consumables segment holds a dominant presence and is expected to grow at the fastest rate in the market during the forecast period.
• By product, the instruments segment shows a notable growth in the sample preparation market during the forecast period.
• By technique, the protein preparation segment will lead the sample preparation market in 2024.
• By technique, the solid-phase extraction segment shows a notable growth in the market during the forecast period.
• By application, the genomics segment holds a dominant presence and is expected to grow at the fastest rate in the market during the forecast period.
• By end use, the diagnostic center segment holds a dominant presence and is expected to grow at the fastest rate in the market during the forecast period.

Industry Valuation and Growth Rate Projection

Sample preparation is a method used to change biological and chemical products into a structure that can be put down directly in an analytical apparatus for future examination. The sample preparation procedure varies depending on the biological or chemical product utilized for analysis. The numerous steps involve extraction, isolation, as well as purification. The quality of the sample utilized for determination can remarkably influence the research's accuracy. The procedure is utilized in biotechnological and pharmaceutical firms, the food and beverage industry, forensic laboratories, and research and academic institutes to observe environmental substances.

Sample Preparation Market: Stats and Figures

• In December 2022, two fragments of Southern Tier Startup Alliance (STSA) incubators, Inso Biosciences and Halomine, were presently awarded about $3 million from the New York State Biodefense Commercialization Fund, through Empire State Development, to assist impede future breakthrough of infectious disorders and to continue increasing the state’s life science companies.

Industry Leader Announcements

• Philippe Mourère, President and CEO, of Stilla Technologies

“The strategic partnership with Promega enhances our value proposition by bringing a fully validated sample-to-answer solution for biomarker testing,” said Philippe Mourère, President and CEO of Stilla Technologies. “Promega has demonstrated the exceptional quality of results from samples processed with their proven reagents on Maxwell systems, which have been adopted globally for liquid biopsies. I am truly excited about the combined reach and strength that we can bring to the market through a strategic partnership.”

• Namyong Kim. PhD, CEO of Curiox Biosystems

"Our alliance with Beckman Coulter Life Sciences is not just about combining technologies; it's about combining our strengths to empower the scientific community," said Namyong Kim. PhD, CEO of Curiox Biosystems. "By addressing the challenges of standardization, automation, and reproducibility head-on, we are paving the way for significant advancements in research and healthcare."

How AI Has Benefitted the Sample Preparation Market

• The incorporation of AI with standard sensors improves decision-making in food safety and packaging, as well as real-time monitoring. Moreover, challenges like ethical concerns, transparency, data security, and high expenses persist.
• AI is transforming drug discovery by permitting virtual screening, predictive analytics, and molecular modeling. These AI models can determine huge amounts of chemical and biological data to detect potential drug candidates, improve lead compounds, and forecast their properties. Ultimately, AI-driven methods contribute to more efficient and effective medications.

Recent Developments

• In December 2024, QIAGEN reported it had held a remarkable milestone with across 1,000 placements, an automated sample preparation apparatus, a development of the EZ1 instrument line.
• In February 2024, Volta Labs reported the foundation of the Callisto Sample Prep System that decreases operational needs and expenses in the clinic and laboratory that were previously expense-prohibitive.

Geographical Insights

The sample preparation market is experiencing significant growth, with North America maintaining its position as the dominant region while Europe emerges as the fastest-growing market. In the APAC region, China stands out as a driver of growth in the space.

North America

North America dominated the global market in 2024. This region’s supremacy is mainly due to its advanced laboratories, strong biotechnology and pharmaceutical industries, and innovative approach. These factors boost the requirement for standard sample preparation methods in North America.

Europe

Europe is experiencing rapid growth in the sample preparation market during the forecast period. It is the center for the latest research and diagnostics globally, so automated sample preparation solutions are very important. The proteomics, genomics, and clinical diagnostics industries demand high-throughput systems that can tackle a substantial number of samples with little help from humans. The requirement for scalable, automated solutions has risen as advanced diagnostics and customized medicine gain popularity across Europe.

China and APAC

Asia Pacific (APAC) is projected to be the fastest growing in the market during the forecast period. This region's expansion is boosted by its stretching life sciences areas and industrial

development. Countries such as China and India are growing in their acceptance of sequencing technologies for numerous applications, which include personalized medicine. The target on proteomics and genomics research in the Asia Pacific provides remarkable growth opportunities for the sample preparation market.

• Company Name: Illumina Inc.
• Year of Incorporation: 1998
• Headquarters: San Diego, California, United States

The competitive landscape of Illumina is a continuously evolving space, with the firm maintaining its position as a chief in genetic and genomics analysis. As developments in technology and research constantly shape the industry, Illumina tackles competition from both renowned players and emerging startups, each competing for a piece of the market share.

• Company Name: Bio-RAD Laboratories Inc.
• Year of Incorporation: 1957
• Headquarters: Hercules, California, United States

With a focus on offering high-quality solutions for the clinical diagnostics and life sciences industries, Bio-Rad has formed itself as a major player in the market.

• Company Name: Merck KGaA
• Year of Incorporation: 1668
• Headquarters: Darmstadt, Germany

Merck KGaA is included in the manufacturer of chemical and pharmaceutical products. The Healthcare zone develops and producers' prescription drugs that treat cancer, multiple sclerosis, and infertility.